1. Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
   Aya Saleh et al, 2021, Cancers CrossRef
2. PLAC1: biology and potential application in cancer immunotherapy
   Jafar Mahmoudian et al, 2019, Cancer Immunology, Immunotherapy CrossRef
3. Placenta-specific protein 1 (PLAC1) expression is significantly down-regulated in preeclampsia via a hypoxia-mediated mechanism
   Eric J. Devor et al, 2024, The Journal of Maternal-Fetal & Neonatal Medicine CrossRef
4. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
   Ryusuke Hayashi et al, 2021, OncoImmunology CrossRef
5. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
   Kaipeng Xie et al, 2019, Journal of Ovarian Research CrossRef
6. Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR
   Stavros Sifakis et al, 2018, Molecular Medicine Reports CrossRef
7. The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells
   Eric J. Devor et al, 2021, Pharmaceuticals CrossRef
8. Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling
   JIANLING BI et al, 2020, Clinical Obstetrics & Gynecology CrossRef
9. Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
   Rashmi Gupta et al, 2022, Epigenomics CrossRef